Nabriva Therapeutics plc Business Finance Contracts & Agreements

20 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Asset Purchase Agreement, dated as of July 30, 2023, by and among Nabriva Therapeutics plc, Nabriva Therapeutics Ireland DAC, Nabriva Therapeutics US, Inc., Nabriva Therapeutics...
Purchase Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2023
Purchase Agreement dated September 24, 2021 between Nabriva Therapeutics plc and Lincoln Park Capital Fund, LLC
Purchase Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2021
Registration Rights Agreement dated September 24, 2021 between Nabriva Therapeutics plc and Lincoln Park Capital Fund, LLC
Registration Rights Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2021
Assignment, Assumption and Novation agreement, by and among Nabriva Therapeutics Ireland Designated Activity Company, Nabriva Therapeutics GmbH, Roivant Sciences Ltd., Roivant...
Assignment Agreements
Nabriva Therapeutics plc
Pharmaceuticals
2021
Fourth Amendment to Loan and Security Agreement, dated as of June 2, 2021, by and among Nabriva Therapeutics Public Limited Company, Nabriva Therapeutics Ireland Designated...
Loan Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2021
Form of Securities Purchase Agreement, dated March 1, 2021, by and among Nabriva Therapeutics plc and the purchasers party thereto
Purchase Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2021
Form of Pre-Funded Warrant
Warrant Agreements
Nabriva Therapeutics plc
Pharmaceuticals
2021
Form of Ordinary Share Warrant
Warrant Agreements
Nabriva Therapeutics plc
Pharmaceuticals
2021
Form of Securities Purchase Agreement, dated December 10, 2020, by and among Nabriva Therapeutics plc and the purchasers party thereto
Purchase Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2020
Form of Securities Purchase Agreement, dated May 29, 2020, by and among Nabriva Therapeutics plc and the purchasers party thereto
Purchase Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2020
Form of Warrant
Warrant Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2020
Third Amendment to Loan and Security Agreement, dated as of March 11, 2020, by and among Nabriva Therapeutics Public Limited Company, Nabriva Therapeutics Ireland Designated...
Loan Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2020
Second Amendment to Loan and Security Agreement, dated as of January 8, 2020, by and among Nabriva Therapeutics Public Limited Company, Nabriva Therapeutics Ireland Designated...
Loan Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2020
Form of Securities Purchase Agreement, dated December 20, 2019, by and among Nabriva Therapeutics plc and the purchasers party thereto
Purchase Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2019
Form of Warrant
Warrant Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2019
First Amendment to Loan and Security Agreement, dated as of September 26, 2019, by and among Nabriva Therapeutics Public Limited Company, Nabriva Therapeutics Ireland Designated...
Loan Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2019
Loan and Security Agreement, dated as of December 20, 2018, by and among Nabriva Therapeutics plc, Nabriva Therapeutics Ireland DAC, certain other subsidiaries of Nabriva...
Loan Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2019
Stock Purchase Agreement by and among SG Pharmaceuticals, Inc., the Sellers named on Annex A, and Julia Feliciano, as Sellers Representative, dated as of May 5, 2015
Stock Agreements
Nabriva Therapeutics plc
Pharmaceuticals
CA
2018
Underwriting Agreement, dated July 26, 2018, by and among Nabriva Therapeutics plc and Morgan Stanley & Co. LLC, as representative of the underwriters named therein
Underwriting Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2018
Underwriting Agreement, dated September 19, 2017, by and among Nabriva Therapeutics plc and Morgan Stanley & Co. LLC and Merrill Lynch, Pierce, Fenner & Smith Incorporated, as...
Underwriting Agreements
Nabriva Therapeutics plc
Pharmaceuticals
NY
2017